Trends in MDS and AML from ASH 2023

被引：0
|
作者：
Pfeilstoecker, Michael [1 ]
机构：
[1] Hanusch Hosp, Med Dept 3, H Collinstr 30, A-1140 Vienna, Austria
来源：
MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY | 2024年 / 17卷 / 03期
关键词：
Acute myeloid leukemia; Myelodysplastic neoplasms; Clonal hematopoiesis; Targeted molecular therapy; Allogeneic transplantation;
D O I：
10.1007/s12254-024-00984-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Presentations in the field of clonal myeloid diseases from the 65th American Society of Hematology conference provided insights into future therapeutic approaches especially for the subset of older patients. While new drugs and concepts for acute myeloid leukemia need further work before clinical implementation, some data on myelodysplastic neoplasms providing new treatment options for transfusion-dependent low-risk patients are already practice-changing.
引用
收藏
页码：178 / 181
页数：4
相关论文
共 50 条
  • [1] Current status and trends in the diagnostics of AML and MDS
    Shumilov, Evgenii
    Flach, Johanna
    Kohlmann, Alexander
    Banz, Yara
    Bonadies, Nicolas
    Fiedler, Martin
    Pabst, Thomas
    Bacher, Ulrike
    BLOOD REVIEWS, 2018, 32 (06) : 508 - 519
  • [2] Key Takeaways From ASH 2023: Emerging Trends in Hematologic Oncology
    Vose, Julie M.
    ONCOLOGY-NEW YORK, 2024, 38 (02):
  • [3] AML / MDS
    Bone Marrow Transplantation, 2002, 29 (Suppl 2) : S54 - S57
  • [4] Magrolimab in MDS and AML
    Cookson, Emma
    LANCET HAEMATOLOGY, 2020, 7 (07): : E505 - E505
  • [5] MDS PROGRESSION TO AML
    Murray, Cindy
    LEUKEMIA RESEARCH, 2021, 108 : S60 - S60
  • [6] FROM MDS TO AML: CHANGE IN THE GENE EXPRESSION PROFILE
    Maria, Abaigar
    Sara, Aibar
    Rocio, Benito
    Maria, Diez-Campelo
    Fernando, Ramos
    Eva, Lumbreras
    Francisco J, Campos-Laborie
    Marta, Megido
    Isabel, Recio
    Lourdes, Hermosin
    Javier, Sanchez-del-Real
    Carmen, Olivier
    Rebeca, Cuello
    Lurdes, Zamora
    Isabel, Isidro
    Ken, Mills
    Consuelo, Del Canizo M.
    Javier, De Las Rivas
    Jesus M, Hernandez-Rivas
    HAEMATOLOGICA, 2016, 101 : 149 - 149
  • [7] AML1 mutations induced MDS and MDS/AML in a mouse BMT model
    Watanabe-Okochi, Naoko
    Kitaura, Jiro
    Ono, Ryoichi
    Harada, Hironori
    Harada, Yuka
    Komeno, Yukiko
    Nakajima, Hideaki
    Nosaka, Tetsuya
    Inaba, Toshiya
    Kitamura, Toshio
    BLOOD, 2008, 111 (08) : 4297 - 4308
  • [8] Hapoloidentical stem cell transplantation for MDS and MDS/AML
    Kim, Y. J.
    Shin, S. H.
    Yoon, J. H.
    Yahng, S. A.
    Lee, S. E.
    Hong, D. S.
    Park, J. W.
    LEUKEMIA RESEARCH, 2013, 37 : S120 - S120
  • [9] Epigenetic modifications in AML and MDS
    Mahmud, Mohammad
    Stebbing, Justin
    LEUKEMIA RESEARCH, 2010, 34 (02) : 139 - 140
  • [10] Genetic deletions in AML and MDS
    Ebert, Benjamin L.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2010, 23 (04) : 457 - 461
12345